Final Agenda Now Available

Today, biospecimen collections are used by multiple research groups for various research aims, from basic research through clinical trials. Useful biosamples must be collected to maintain their molecular integrity for specific (or unknown) downstream analysis. Thus, the proper collection, processing, storage and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Cambridge Healthtech Institute’s 8th International Leaders in Biobanking Congress: Applying Biospecimen Science to Advance Biomedical Research and Patient Care addresses biospecimen science, management, and applications, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.

KEYNOTE PRESENTATION
Eric DishmanThe NIH Precision Medicine Initiative: The Potential of a Million

Eric Dishman, Director, Precision Medicine Initiative Cohort Program, National Institutes of Health


Wednesday, September 7

 

Thursday – Friday, September 8-9

Explore How Biobanks Facilitate Personalized Medicine:

  • Case Study Co-Presentations on Biobanker/R&D Partnerships
  • Research Applications to Circulating Genomic Material
  • Fit-for-Purpose Biospecimens and Biomarkers from Biobanks
 

Hosted By
 



For more details on the conference, please contact:
Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: (+1) 781-972-5497

Email: mabrown@healthtech.com

For sponsorship and exhibit sales information, please contact:
Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email:
cbenton@healthtech.com